AIDS therapy and vaccine
US5935579A · kind A · utility
8Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 1994 |
| Grant date | Aug 10, 1999 |
| Priority date | — |
| Expiry date | Oct 14, 2014 |
Classification
- Technology area (CPC F)Mechanical Engineering; Lighting; Heating
- CPC primaryF02B2075/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides therapy and prophylaxis against HIV-induced AIDS, as well as methods for ascertaining the susceptibility of an individual to HIV-induced AIDS, the invention being based on the discovery that AIDS results from gp120 of HIV mimicking the antigen-presenting component of the immune system, thereby spuriously activating certain CD4+ T cells in susceptible individuals, leading to a condition similar to graft versus host disease, the condition being treatable by eliminating the responsible T cells, for example.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.